Hong Kong IPOs – Company Side:
- Sinotau in its proposed Hong Kong IPO (ongoing)
- Huahui Health in its proposed Hong Kong IPO (ongoing)
- Zephyrm Biotech in its proposed Hong Kong IPO (ongoing)
- S.F. Holding Co., Ltd. (6936.HK) in its approximately HK$5.8 billion IPO and listing on the Hong Kong Stock Exchange*
- JL MAG RARE-EARTH CO., LTD. (6680.HK) in its approximately HK$4 billion IPO and listing on the Hong Kong Stock Exchange*
- Mediwelcome Healthcare Management & Technology Inc. (2159.HK) in its approximately HK$160 million IPO and listing on the Hong Kong Stock Exchange*
- Jiangsu Innovative Ecological New Materials Limited (2116.HK)* in its approximately HK$150 million IPO and listing on the Hong Kong Stock Exchange*
- Inner Mongolia Energy Engineering Co., Ltd. (1649.HK) in its approximately HK$1.1 billion IPO and listing on the Hong Kong Stock Exchange*
Hong Kong IPOs – Sponsor Side:
- CICC and CMS as joint sponsors in the approximately HK$600 million IPO and listing of QingSong Health Corporation (2661.HK) on the Hong Kong Stock Exchange*
- CITICS and CICC as joint sponsors in the approximately HK$680 million IPO and listing of Guangzhou Innogen Pharmaceutical Group Co., Ltd. (2591.HK) on the Hong Kong Stock Exchange*
- CICC as the sole sponsor in the approximately HK$460 million IPO and listing of Sunho Biologics, Inc. (2898.HK) on the Hong Kong Stock Exchange*
- CITICS as the sole sponsor in the approximately HK$1.04 billion IPO and listing of XtalPi Inc. (2228.HK) on the Hong Kong Stock Exchange*
- CICC and CITICS as joint sponsors in the A+H listing of JA Solar Technology Co., Ltd. on the Hong Kong Stock Exchange*
- CITICS and Fosun International as joint sponsors in the proposed Hong Kong IPO of Boche Holding Limited (Cayman)*
- Huatai International as the sole sponsor in the approximately HK$460 million IPO and listing of AuGroup (SHENZHEN) Cross-Border Business Co., Ltd. (2519.HK) on the Hong Kong Stock Exchange*
- CICC as the sole sponsor in the approximately HK$310 million IPO and listing of Xiamen Yan Palace Bird's Nest Industry Co., Ltd. (1497.HK) on the Hong Kong Stock Exchange*
- CICC as the sole sponsor in the approximately HK$640 million IPO and listing of Xikang Cloud Hospital Holdings Inc. (9686.HK) on the Hong Kong Stock Exchange*
- CICC and GS as joint sponsors in the proposed Hong Kong IPO of Neusoft Medical*
- CICC and China Securities as joint sponsors in the approximately HK$410 million IPO and listing of 3D Medicines Inc. (1244.HK) on the Hong Kong Stock Exchange*
- CMBC International as the sole sponsor in the approximately HK$1.09 billion IPO and listing of UJU HOLDINGLIMITED (1948.HK) on the Hong Kong Stock Exchange*
- Shenwan Hongyuan as the sole sponsor in the approximately HK$130 million IPO and listing of Desun Real Estate Investment Services Group Co., Ltd. (2270.HK) on the Hong Kong Stock Exchange*
- China Securities as the sole sponsor in the HK$60 million IPO and listing of Doumob (1917.HK) on the Hong Kong Stock Exchange*
- CICC, MS, BofA, GS, JPM as joint sponsors in the US$7.43 billion IPO and listing of Postal Savings Bank of China Co., Ltd. (1658.HK) on the Hong Kong Stock Exchange*
Other Capital Markets Experience
- China Huaneng Group (Hong Kong) Treasury Management Holding Limited (5089.HK) in the offering of US$500 million subordinated guaranteed perpetual securities*
- Newborn Town Inc. (9911.HK) in its approximately HK$350 million placing of new H shares under general mandate*
- Newborn Town Inc. (9911.HK) in an equity acquisition transaction*
- SINOPEC SEG (2386.HK) in its major transactions*
- Qinghuangdao Port (3369.HK) in its major transactions*
- Fusi Capital in its equity investment in an education company*
- DSHL, Inc. in its Series B financing*
- BAIC BJEV in its equity investment in a battery manufacturing company*
Compliance Matters:
- Advised the following Hong Kong-listed companies on compliance matters, including: INT Medical Instruments (1501.HK), Fosun Pharma (2196.HK)*, Bank of Communications Co., Ltd. (3328.HK)*, China Merchants Bank Co., Ltd (3968.HK)*, Newborn Town Inc. (9911.HK)*, SINOPEC Engineering (Group) Co., Ltd. (2386.HK)*, Qinhuangdao Port Co., Ltd. (3369.HK)*, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)*, and E-Commodities Holdings Limited (fka. Winsway Enterprises Holding Limited) (1733.HK)*
* Work performed prior to joining O’Melveny
Languages
- English
- Mandarin Chinese
Admissions
- New York
Education
- Boston University School of Law, LL.M.
- China University of Political Science and Law, LL.B.
Professional Activities
Bar Exam
- Passed Chinese Bar Exam
Related Practices
Related Regions